Intra-Cellular Therapies stock jumps 34%: Can it ride the wave?
Intra-Cellular Therapies Inc. shares soared 34.07% today, closing at $127.19 after gaining $32.32, driven by the announcement of its acquisition by Johnson & Johnson for $14.6 billion. The deal offers...
How insider selling triggered Nauticus Robotics’ 33% stock slide
Nauticus Robotics Inc. shares nosedived 32.79% today, closing at $2.07, down $1.01 in a turbulent trading session. The plunge follows news that the company’s CEO sold 3,190 shares earlier this week,...
Why SEALSQ shares plunged 42% despite strong financial projections
SEALSQ Corp’s stock plummeted by 41.54% today, closing at $3.35 after losing $2.38 per share. The dramatic drop followed the company’s announcement of a strong financial position, with expectation...
Trump Media surges 21%, Dow futures climb: What to watch today
Dow Jones futures rose along with S&P 500 futures and Nasdaq 100 futures ahead of Tuesday’s market opening, following gains in Monday’s stock market action.
U.S. futures rise as Trump Media stock ...
Is AMD stock undervalued: Why now could be the perfect time to buy
Advanced Micro Devices, Inc. (NASDAQ: AMD) has faced analyst downgrades, resulting in its stock trading at recent lows, which some consider a buying opportunity. The company is slated to report Q4 202...
Is Rivian stock a buy: 5 key reasons to invest before February 20
Rivian (NASDAQ: RIVN) is set to release its fourth quarter 2024 and full year 2024 earnings on February 20, and the outlook for 2025 is anticipated to be more optimistic than the previous year.
Rivian...